{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:44Z","timestamp":1787020844945,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Presently, it is known that, even if less frequently than in adults, children can develop a severe new coronavirus disease 2019 (COVID-19). Children with the SARS-CoV-2 infection can have neurological signs and symptoms of disease more frequently than previously thought, revealing the involvement of the central nervous system, the peripheral nervous system, or both. Aim of this manuscript is to highlight the neurologic complications associated with SARS-CoV-2 among pediatric patients with COVID-19, suggesting when to monitor carefully neurologic development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main findings<\/jats:title>\n                    <jats:p>Children with a severe chronic underlying disease, infants and toddlers and those who develop the so-called multisystem inflammatory syndrome (MIS-C) are those with the highest incidence of neurological complications. Fortunately, in most of the cases, neurological manifestations, mainly represented by headache and anosmia, are mild and transient and do not significantly complicate the COVID-19 course. However, in some cases, very severe clinical problems associated with relevant alterations of neuroimaging, electroencephalography, nerve conduction studies and electromyography findings can develop. Generally, almost all the children with COVID-19 and neurological manifestations till now described have made a complete recovery, although in some cases this has occurred after several weeks of treatment. Moreover, COVID-19 infection during pregnancy has been found associated with an increased risk of obstetric complications that can lead to neurological acute and long-term manifestations in neonates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on data showing the neurologic impact of COVID-19 in pediatric age, we suggest monitoring neurological development a few months after healing in pediatric patients who have presented MIS-C, seizures or other neurological manifestations and in children of pregnant women with COVID-19 in order to detect overt and subtle deficits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-021-01144-y","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T13:02:47Z","timestamp":1631970167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated?"],"prefix":"10.1186","volume":"47","author":[{"given":"Nicola","family":"Principi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"issue":"6","key":"1144_CR1","doi-asserted-by":"publisher","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","volume":"145","author":"Y Dong","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. https:\/\/doi.org\/10.1542\/peds.2020-0702.","journal-title":"Pediatrics."},{"key":"1144_CR2","doi-asserted-by":"publisher","first-page":"575290","DOI":"10.3389\/fped.2020.575290","volume":"8","author":"G Vergine","year":"2020","unstructured":"Vergine G, Fantini M, Marchetti F, Stella M, Valletta E, Biasucci G, et al. Esposito S; Regione Emilia-Romagna COVID-19 Pediatric Working Group (RERCOPed). Home Management of Children With COVID-19 in the Emilia-Romagna Region, Italy. Front Pediatr. 2020;8:575290.","journal-title":"Front Pediatr"},{"issue":"8","key":"1144_CR3","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.3390\/ijerph18083919","volume":"18","author":"S Esposito","year":"2021","unstructured":"Esposito S, Marchetti F, Lanari M, Caramelli F, De Fanti A, Vergine G, et al. Working group on COVID-19 in pediatrics of the Emilia-Romagna region (RE-CO-Ped). COVID-19 Management in the Pediatric age: consensus document of the COVID-19 working Group in Paediatrics of the Emilia-Romagna region (RE-CO-Ped), Italy. Int J Environ Res Public Health. 2021;18(8):3919. https:\/\/doi.org\/10.3390\/ijerph18083919.","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"1144_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2352-4642(20)30177-2","volume":"4","author":"F G\u00f6tzinger","year":"2020","unstructured":"G\u00f6tzinger F, Santiago-Garc\u00eda B, Noguera-Juli\u00e1n A, Lanaspa M, Lancella L, Cal\u00f2 Carducci FI, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653\u201361. https:\/\/doi.org\/10.1016\/S2352-4642(20)30177-2.","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"1144_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13052-021-01057-w","volume":"47","author":"S Esposito","year":"2021","unstructured":"Esposito S, Caramelli F, Principi N. What are the risk factors for admission to the pediatric intensive unit among pediatric patients with COVID-19? Ital J Pediatr. 2021;47(1):103. https:\/\/doi.org\/10.1186\/s13052-021-01057-w.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"1144_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2102968","volume":"385","author":"AJ McArdle","year":"2021","unstructured":"McArdle AJ, Vito O, Patel H, Seaby EG, Shah P, Wilson C, et al. Treatment of multisystem inflammatory syndrome in children. N Engl J Med. 2021;385(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa2102968.","journal-title":"N Engl J Med"},{"key":"1144_CR7","doi-asserted-by":"publisher","unstructured":"Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Me-ta-Analysis. J Trop Pediatr. 2020; Epub Sep 10:fmaa070. doi: https:\/\/doi.org\/10.1093\/tropej\/fmaa070, 2021.","DOI":"10.1093\/tropej\/fmaa070"},{"issue":"2","key":"1144_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40272-020-00435-x","volume":"23","author":"S Esposito","year":"2021","unstructured":"Esposito S, Principi N. Multisystem inflammatory syndrome in children related to SARS-CoV-2. Paediatr Drugs. 2021;23(2):119\u201329. https:\/\/doi.org\/10.1007\/s40272-020-00435-x.","journal-title":"Paediatr Drugs"},{"key":"1144_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pediatrneurol.2021.01.007","volume":"117","author":"TG Singer","year":"2021","unstructured":"Singer TG, Evankovich KD, Fisher K, Demmler-Harrison GJ, Risen SR. Coronavirus infections in the nervous system of children: a scoping review making the case for long-term neurodevelopmental surveillance. Pediatr Neurol. 2021;117:47\u201363. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.01.007.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"1144_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3201\/eid1602.090469","volume":"16","author":"N Principi","year":"2010","unstructured":"Principi N, Bosis S, Esposito S. Effects of coronavirus infections in children. Emerg Infect Dis. 2010;16(2):183\u20138. https:\/\/doi.org\/10.3201\/eid1602.090469.","journal-title":"Emerg Infect Dis"},{"key":"1144_CR11","doi-asserted-by":"publisher","unstructured":"Schober ME, Pavia AT, Bohnsack JF. Neurologic manifestations of COVID-19 in children: emerging pathophysiologic insights. Pediatr Crit Care Med. 2021; Epub May 7. doi: https:\/\/doi.org\/10.1097\/PCC.0000000000002774.","DOI":"10.1097\/PCC.0000000000002774"},{"issue":"3","key":"1144_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2352-4642(20)30362-X","volume":"5","author":"CE Lindan","year":"2021","unstructured":"Lindan CE, Mankad K, Ram D, Kociolek LK, Silvera VM, Boddaert N, et al. Neu-roimaging manifestations in children with SARS-CoV-2 infection: a multinational, Mul-ticentre collaborative study. Lancet Child Adolesc Health. 2021;5(3):167\u201377. https:\/\/doi.org\/10.1016\/S2352-4642(20)30362-X.","journal-title":"Lancet Child Adolesc Health."},{"issue":"1","key":"1144_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13052-021-01066-9","volume":"47","author":"L Siracusa","year":"2021","unstructured":"Siracusa L, Cascio A, Giordano S, Medaglia AA, Restivo GA, Pirrone I, et al. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature. Ital J Pediatr. 2021;47(1):123. https:\/\/doi.org\/10.1186\/s13052-021-01066-9.","journal-title":"Ital J Pediatr"},{"issue":"20","key":"1144_CR14","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1001\/jama.2021.6210","volume":"325","author":"D Dumitriu","year":"2021","unstructured":"Dumitriu D, Gyamfi-Bannerman C. Understanding risk for newborns born to SARS-CoV-2\u2013positive mothers. JAMA. 2021;325(20):2051\u20132. https:\/\/doi.org\/10.1001\/jama.2021.6210.","journal-title":"JAMA."},{"key":"1144_CR15","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.05018","volume":"11","author":"ZS Lassi","year":"2021","unstructured":"Lassi ZS, Ana A, Das JK, Salam RA, Padhani ZA, Irfan O, et al. A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity. J Glob Health. 2021;11:05018. https:\/\/doi.org\/10.7189\/jogh.11.05018.","journal-title":"J Glob Health"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-021-01144-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T13:02:53Z","timestamp":1631970173000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-021-01144-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1186\/s13052-021-01144-y","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,18]]},"assertion":[{"value":"5 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}